Mayte Pérez‐Olmeda
Dados Biográficos
| ID | 9120713 |
|---|---|
| NOME | Mayte Pérez‐Olmeda |
| PRENOMES | Mayte |
| SOBRENOME | Pérez‐Olmeda |
| ASSINATURA | OLMEDA M P |
| AFILIAÇÕES | Instituto de Salud Carlos III |
| ORCID | 0000-0003-4553-5423 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 5 |
| TOTAL DE CITAÇÕES | 1 |
| TOTAL COMO AUTOR | 5 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2020 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2025 |
| ÍNDICE H | 1 |
Revisión De La Estrategia De Vacunación Frente a Sarampión Tras Los Resultados Del Segundo Estudio De Seroprevalencia en España
Sars-CoV-2 Infection During the First and Second Pandemic Waves in Spain
Objectives. To describe participant characteristics associated with severe acute respiratory syndrome coronavirus 2 infection in Spain’s first 2 COVID-19 waves per the Spanish National Seroepidemiological Survey of SARS-CoV-2 Infection (ENE–COVID). Methods. A representative cohort of the noninstitutionalized Spanish population, selected through stratified 2-stage sampling, answered a questionnaire and received point-of-care testing April to June …
Design and Implementation of a Nationwide Population-Based Longitudinal Survey of Sars-CoV-2 Infection in Spain
Data System. The Spanish National Seroepidemiological Survey of SARS-CoV-2 (or ENE-COVID; SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] is the causative agent of COVID-19) was funded by the Spanish Ministry of Health, the Instituto de Salud Carlos III, and the Spanish National Health System. Data Collection/Processing. A stratified 2-stage probability sampling was used to select a representative cohort of the noninstitutionalized p…
Mapping of serological testing and Sars-CoV-2 seroprevalence studies performed in 20 European countries, March-June 2020
BACKGROUND: The SARS-CoV-2 pandemic spread across Europe from February 2020. While robust SARS-CoV-2 serological assays were quickly developed, only limited information on applied serological testing is available. We describe the extent and nature of SARS-CoV-2 serological testing used in Europe and assess the links between epidemiology, mitigation strategies applied and seroprevalence. METHODS: An online questionnaire on SARS-CoV-2 serology was …
Prevalence of Sars-CoV-2 in Spain (ENE-Covid)
Sars-CoV-2 Infection During the First and Second Pandemic Waves in Spain
Objectives. To describe participant characteristics associated with severe acute respiratory syndrome coronavirus 2 infection in Spain’s first 2 COVID-19 waves per the Spanish National Seroepidemiological Survey of SARS-CoV-2 Infection (ENE–COVID). Methods. A representative cohort of the noninstitutionalized Spanish population, selected through stratified 2-stage sampling, answered a questionnaire and received point-of-care testing April to June …
Prevalence of Sars-CoV-2 in Spain (ENE-Covid)
Mapping of serological testing and Sars-CoV-2 seroprevalence studies performed in 20 European countries, March-June 2020
BACKGROUND: The SARS-CoV-2 pandemic spread across Europe from February 2020. While robust SARS-CoV-2 serological assays were quickly developed, only limited information on applied serological testing is available. We describe the extent and nature of SARS-CoV-2 serological testing used in Europe and assess the links between epidemiology, mitigation strategies applied and seroprevalence. METHODS: An online questionnaire on SARS-CoV-2 serology was …
Sars-CoV-2 Infection During the First and Second Pandemic Waves in Spain
Objectives. To describe participant characteristics associated with severe acute respiratory syndrome coronavirus 2 infection in Spain’s first 2 COVID-19 waves per the Spanish National Seroepidemiological Survey of SARS-CoV-2 Infection (ENE–COVID). Methods. A representative cohort of the noninstitutionalized Spanish population, selected through stratified 2-stage sampling, answered a questionnaire and received point-of-care testing April to June …
Design and Implementation of a Nationwide Population-Based Longitudinal Survey of Sars-CoV-2 Infection in Spain
Data System. The Spanish National Seroepidemiological Survey of SARS-CoV-2 (or ENE-COVID; SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] is the causative agent of COVID-19) was funded by the Spanish Ministry of Health, the Instituto de Salud Carlos III, and the Spanish National Health System. Data Collection/Processing. A stratified 2-stage probability sampling was used to select a representative cohort of the noninstitutionalized p…
Revisión De La Estrategia De Vacunación Frente a Sarampión Tras Los Resultados Del Segundo Estudio De Seroprevalencia en España
Medicine (4 obras) · 2019-20 coronavirus outbreak (3 obras) · Coronavirus disease 2019 (COVID-19) (3 obras) · Coronavirus Infections (3 obras) · COVID-19 Clinical Research Studies (3 obras) · Disease (3 obras) · Infectious disease (medical specialty) (3 obras) · Outbreak (3 obras) · Pandemic (3 obras) · Pathology (3 obras)